Medtronic EVP Kweli reports 30,017 share holding
Medtronic plc EVP & President, Neuroscience Thompson Kweli filed an initial Form 3 showing his current equity holdings in the company.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Medtronic plc EVP & President, Neuroscience Thompson Kweli filed an initial Form 3 showing his current equity holdings in the company. He directly owns 30,017.737 ordinary shares and holds multiple stock option grants with varying exercise prices and expirations, plus performance share units that may convert into additional shares based on future vesting and performance conditions.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Thompson Kweli
Role
EVP & President, Neuroscience
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Performance Share Unit | -- | -- | -- |
| Holding | Performance Share Units | -- | -- | -- |
| Holding | Performance Share Units | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Stock Option (Right to Buy) | -- | -- | -- |
| Holding | Ordinary Shares | -- | -- | -- |
Holdings:
Performance Share Unit — 3,252.987 contracts (Direct);
Performance Share Units — 19,089.996 contracts (Direct);
Stock Option (Right to Buy) — 108,345 contracts (Direct);
Ordinary Shares — 30,017.737 shares (Direct)
Footnotes (9)
- F1. Includes 6,549 performance stock units that vested on April 24, 2026; 1,822 restricted stock units that vested on December 6, 2025; 3,742.990 restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026; 9,911.187 restricted stock units that vest on July 29, 2027; 4,589.916 restricted stock units that vest on July 28, 2028.
- F2. The performance share units ("PSUs") vest on December 6, 2026.
- F3. The number of shares to be issued in connection with the PSUs reported reflects the amount earned based on achievement of applicable performance criteria. The award remains subject to time-based vesting.
- F4. Each PSU represents a contingent right to receive one share of Medtronic common stock.
- F5. The PSUs vest on April 30, 2027.
- F6. The number of shares to be issued in connection with PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,911.187 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- F7. The PSUs vest on April 28, 2028.
- F8. The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,178.809 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- F9. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Key Figures
Direct ordinary share holdings: 30,017.737 shares
Option grant at $91.97: 22,363 underlying shares at $91.97
Option grant at $87.76: 25,408 underlying shares at $87.76
+5 more
8 metrics
Direct ordinary share holdings
30,017.737 shares
Directly owned Medtronic ordinary shares reported on Form 3
Option grant at $91.97
22,363 underlying shares at $91.97
Stock option (right to buy), expires July 28, 2035
Option grant at $87.76
25,408 underlying shares at $87.76
Stock option (right to buy), expires July 31, 2033
Option grant at $93.08
26,890 underlying shares at $93.08
Stock option (right to buy), expires August 1, 2032
Performance share units 2027 target
9,911.187 shares
Target shares from PSUs vesting July 29, 2027 if metrics met
Performance share units 2028 target
9,178.809 shares
Target shares from PSUs vesting April 28, 2028 if metrics met
PSU vesting date
December 6, 2026
One PSU award vests on this date per footnotes
RSUs vesting July 31, 2026
3,742.990 units
Restricted stock units scheduled to vest on July 31, 2026
Key Terms
Performance Share Units, restricted stock units, stock option (right to buy, exercise price, +2 more
6 terms
restricted stock units financial
"restricted stock units that vest on July 31, 2026; 3,402.644 restricted stock units that vest on December 6, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option (right to buy financial
"Stock Option (Right to Buy) with various exercise prices and expiration dates"
exercise price financial
"The number of shares to be issued in connection with the PSUs will vary depending on the level of certain performance metrics achieved"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The award remains subject to time-based vesting."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
performance metrics financial
"will vary depending on the level of certain performance metrics achieved over a three (3) year performance period."
Performance metrics are concrete numbers or ratios that show how well a business, product, or investment is doing—like speed, fuel use and mileage on a car’s dashboard. They measure things investors care about, such as sales growth, profitability, cash flow, customer retention or efficiency, so readers can compare progress, spot strengths or problems, and make informed decisions about buying, holding or selling shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
